These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26038527)

  • 1. Glomerular Effects of Age and APOL1.
    Meyer TW; Lenihan CR
    J Am Soc Nephrol; 2015 Dec; 26(12):2901-3. PubMed ID: 26038527
    [No Abstract]   [Full Text] [Related]  

  • 2. APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study.
    Hoy WE; Hughson MD; Kopp JB; Mott SA; Bertram JF; Winkler CA
    J Am Soc Nephrol; 2015 Dec; 26(12):3179-89. PubMed ID: 26038529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.
    Lan X; Jhaveri A; Cheng K; Wen H; Saleem MA; Mathieson PW; Mikulak J; Aviram S; Malhotra A; Skorecki K; Singhal PC
    Am J Physiol Renal Physiol; 2014 Aug; 307(3):F326-36. PubMed ID: 24899058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.
    Beckerman P; Bi-Karchin J; Park AS; Qiu C; Dummer PD; Soomro I; Boustany-Kari CM; Pullen SS; Miner JH; Hu CA; Rohacs T; Inoue K; Ishibe S; Saleem MA; Palmer MB; Cuervo AM; Kopp JB; Susztak K
    Nat Med; 2017 Apr; 23(4):429-438. PubMed ID: 28218918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target organ damage in African American hypertension: role of APOL1.
    Freedman BI; Murea M
    Curr Hypertens Rep; 2012 Feb; 14(1):21-8. PubMed ID: 22068337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOL1 and kidney disease: new insights leading to novel therapies.
    Freedman BI
    Am J Kidney Dis; 2015 Jul; 66(1):9-11. PubMed ID: 26111904
    [No Abstract]   [Full Text] [Related]  

  • 7. APOL1 localization in normal kidney and nondiabetic kidney disease.
    Madhavan SM; O'Toole JF; Konieczkowski M; Ganesan S; Bruggeman LA; Sedor JR
    J Am Soc Nephrol; 2011 Nov; 22(11):2119-28. PubMed ID: 21997392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOL1 and kidney disease.
    Pollak MR; Genovese G; Friedman DJ
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):179-82. PubMed ID: 22257798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein l1 and the genetic basis for racial disparity in chronic kidney disease.
    Quaggin SE; George AL
    J Am Soc Nephrol; 2011 Nov; 22(11):1955-8. PubMed ID: 21997393
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
    Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new era of APOL1-associated glomerulosclerosis.
    Freedman BI; Langefeld CD
    Nephrol Dial Transplant; 2012 Apr; 27(4):1288-91. PubMed ID: 22302261
    [No Abstract]   [Full Text] [Related]  

  • 12. Cells of renin lineage take on a podocyte phenotype in aging nephropathy.
    Pippin JW; Glenn ST; Krofft RD; Rusiniak ME; Alpers CE; Hudkins K; Duffield JS; Gross KW; Shankland SJ
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1198-209. PubMed ID: 24647714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of focal segmental glomerulosclerosis.
    Jefferson JA; Shankland SJ
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):408-16. PubMed ID: 25168829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
    Anyaegbu EI; Shaw AS; Hruska KA; Jain S
    Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9.
    Genovese G; Tonna SJ; Knob AU; Appel GB; Katz A; Bernhardy AJ; Needham AW; Lazarus R; Pollak MR
    Kidney Int; 2010 Oct; 78(7):698-704. PubMed ID: 20668430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte biology in segmental sclerosis and progressive glomerular injury.
    Barisoni L
    Adv Chronic Kidney Dis; 2012 Mar; 19(2):76-83. PubMed ID: 22449344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Real World Impact of APOL1 Variants on Kidney Transplantation.
    Chandraker A
    Transplantation; 2016 Jan; 100(1):16-7. PubMed ID: 26566059
    [No Abstract]   [Full Text] [Related]  

  • 18. Collapsing glomerulopathy associated lupus in a black female with homozygous APOL1 mutation.
    Kofman T; Narjoz C; Raimbourg Q; Loriot MA; Karras A; Roland M; Hill G; Jacquot C; Nochy D; Thervet E
    Lupus; 2012 Nov; 21(13):1459-62. PubMed ID: 22952321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.
    Hodgin JB; Bitzer M; Wickman L; Afshinnia F; Wang SQ; O'Connor C; Yang Y; Meadowbrooke C; Chowdhury M; Kikuchi M; Wiggins JE; Wiggins RC
    J Am Soc Nephrol; 2015 Dec; 26(12):3162-78. PubMed ID: 26038526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.